115 related articles for article (PubMed ID: 9248859)
1. Enhancement of natural killer cell activity and T and B cell function by buffered vitamin C in patients exposed to toxic chemicals: the role of protein kinase-C.
Heuser G; Vojdani A
Immunopharmacol Immunotoxicol; 1997 Aug; 19(3):291-312. PubMed ID: 9248859
[TBL] [Abstract][Full Text] [Related]
2. Immune alteration associated with exposure to toxic chemicals.
Vojdani A; Ghoneum M; Brautbar N
Toxicol Ind Health; 1992; 8(5):239-54. PubMed ID: 1455435
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations.
Ghayur T; Seemayer TA; Lapp WS
Transplantation; 1987 Aug; 44(2):254-60. PubMed ID: 3498241
[TBL] [Abstract][Full Text] [Related]
4. New evidence for antioxidant properties of vitamin C.
Vojdani A; Bazargan M; Vojdani E; Wright J
Cancer Detect Prev; 2000; 24(6):508-23. PubMed ID: 11198264
[TBL] [Abstract][Full Text] [Related]
5. In vitro effects of vitamin C and selenium on NK activity of patients with beta-thalassemia major.
Atasever B; Ertan NZ; Erdem-Kuruca S; Karakas Z
Pediatr Hematol Oncol; 2006; 23(3):187-97. PubMed ID: 16517535
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event.
Steele TA; Brahmi Z
J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683
[TBL] [Abstract][Full Text] [Related]
7. [Regulation of the natural killer activity of lymphocytes from healthy donors and patients with chronic lympholeukemia through the interaction of T- and non-T cells].
Khonina NA; Shubinskiĭ GZ; Lozovoĭ VP
Biull Eksp Biol Med; 1987 Mar; 103(3):321-3. PubMed ID: 3493815
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation.
Porrata LF; Inwards DJ; Lacy MQ; Markovic SN
Bone Marrow Transplant; 2001 Oct; 28(7):673-80. PubMed ID: 11704790
[TBL] [Abstract][Full Text] [Related]
9. beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells.
Mandler RN; Biddison WE; Mandler R; Serrate SA
J Immunol; 1986 Feb; 136(3):934-9. PubMed ID: 2934481
[TBL] [Abstract][Full Text] [Related]
10. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
[TBL] [Abstract][Full Text] [Related]
11. Cell proliferation and natural killer cell activity by polyherbal formulation, Immu-21 in mice.
Nemmani KV; Jena GB; Dey CS; Kaul CL; Ramarao P
Indian J Exp Biol; 2002 Mar; 40(3):282-7. PubMed ID: 12635697
[TBL] [Abstract][Full Text] [Related]
12. Modulation of CD3- large granular lymphocyte functions by agonist and antagonists of protein kinase C: effects on NK and lymphokine-activated killer activity and production of IFN-gamma.
Ortaldo JR; Young HA; Varesio L
J Immunol; 1989 Jul; 143(1):366-71. PubMed ID: 2543702
[TBL] [Abstract][Full Text] [Related]
13. NK cell function in severe combined immunodeficiency (SCID): evidence of a common T and NK cell defect in some but not all SCID patients.
Peter HH; Friedrich W; Dopfer R; Müller W; Kortmann C; Pichler WJ; Heinz F; Rieger CH
J Immunol; 1983 Nov; 131(5):2332-9. PubMed ID: 6415162
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
[TBL] [Abstract][Full Text] [Related]
15. Genistein modulates splenic natural killer cell activity, antibody-forming cell response, and phenotypic marker expression in F(0) and F(1) generations of Sprague-Dawley rats.
Guo TL; White KL; Brown RD; Delclos KB; Newbold RR; Weis C; Germolec DR; McCay JA
Toxicol Appl Pharmacol; 2002 Jun; 181(3):219-27. PubMed ID: 12079431
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction in activated natural killer cells and natural killer cells inactivated with sensitive targets.
Gibboney JJ; Shenoy AM; Jin X; Brahmi Z
Nat Immun; 1992; 11(2):57-68. PubMed ID: 1498520
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities of peripheral blood T lymphocytes and natural killer cells in alcoholic hepatitis persist after a 3-month withdrawal period.
Laso FJ; Madruga JI; López A; Ciudad J; Alvarez-Mon M; San Miguel J; Orfao A
Alcohol Clin Exp Res; 1997 Jun; 21(4):672-6. PubMed ID: 9194923
[TBL] [Abstract][Full Text] [Related]
18. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
19. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
Miller JS; Tessmer-Tuck J; Pierson BA; Weisdorf D; McGlave P; Blazar BR; Katsanis E; Verfaillie C; Lebkowski J; Radford J; Burns LJ
Biol Blood Marrow Transplant; 1997 Apr; 3(1):34-44. PubMed ID: 9209739
[TBL] [Abstract][Full Text] [Related]
20. Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer.
Robertson MJ; Cameron C; Atkins MB; Gordon MS; Lotze MT; Sherman ML; Ritz J
Clin Cancer Res; 1999 Jan; 5(1):9-16. PubMed ID: 9918197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
